References
- Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initia-tive Randomized Controlled Trial. J Am Med Assoc 2002;288:321–33
- Stevenson JC, Whitehead MI. Hormone replace-ment therapy. Br Med J 2002;325:113–14
- Fletcher SW, Colditz GA. Failure of estrogen plus progestin therapy for prevention. J Am Med Assoc 2002;288:366–8
- Medical Research Council Media release. Trial Steering Committee says MRC Study of long-term use of HRT should continue. Reference: MRC/36/02
- Medical Research Council Media release. MRC to set up international committee to review studies in long-term use of HRT. Reference: MRC/40/02
- Medical Research Council Media release. MRC stops study of long-term use of HRT. Reference: MRC/51/02
- The Women's Health Initiative Study Group. Design of the Women's Health Initiative Clinical Trial and Observational Study. Control Clin Trials 1998;19:61–109
- Wilkes HC, Meade TW. Hormone replacement therapy in general practice: a survey of doctors in the MRC's general practice research framework. Br Med J 1991;302:1317–20
- Vickers M. The MRC long-term randomised controlled trial of hormone replacement therapy: background, design and objectives. J Br Meno-pause Soc 1996;1:October:9–13
- Prince M, Huppert F, Richards M. Investigating the effect of hormone replacement therapy (HRT) on dementia and cognitive function in post-menopausal women (WISDOM-COG). A Women's International Study of long Duration Oestrogen after Menopause (WISDOM) sub-study. Abstract for the MRC General Practice Research Framework Conference, 2002